Professor Jacqui Shaw talks to the Daily Mail about detecting cancer from liquid biopsies
LPMI's Professor Jacqui Shaw is featured in this months issue of Life in the Lab, celebrating women in science
LPMI's Professor Jacqui Shaw interview
LPMI's Professor Jacqui Shaw discussing the Implementation of liquid biopsy testing for management of breast cancer in Mexico as part of the British Council Newton Links Institutional Award. The project will become the foundation to incorporate genomic tests for cancer in Mexico, helping to close the gap in health disparity and providing ethnically diverse data on cancer genomics that will be useful for the wider scientific community worldwide.
AI opportunities in Precision Medicine
On Monday 26th March, 19 academics from across the College of Life Sciences met to discuss opportunities to develop novel AI applications in Precision Medicine for patient benefit.
Professor Jacqui Shaw talks to the Guardian about detecting cancer from a 'liquid biopsy'
Midlands AMS Research Festival 27th March 2019 - call for abstracts in the areas of Cancer, Diabetes, Respiratory Sciences
Congratulations to Professor Jacqui Shaw ,LPMI Director, - one of BioBeat’s 50 Movers and Shakers for 2018
Call for abstracts in the areas of Cancer, Diabetes, Respiratory Sciences - Midlands AMS Research Festival 2019
LPMI committee member, Professor Gerry McCann is awarded prestigious research professorship
The newly published Allocations Booklet sets out how all government science, research and innovation budgets have been allocated until the end of the current Spending Review (March 2021)
The increase announced in Autumn Statement 2016 of additional National Productivity Investment Funding is included in the publication.
The Midlands Innovation Commercialisation of Research Accelerator (MICRA) project gets underway by publishing its first IP Opportunities listing
Through MICRA, Midlands Innovation is establishing the UK's largest, formal technology transfer office collaboration, with the ambition to create a single gateway to the collective Intellectual Property (IP) resources of the eight Midlands Innovation universities.
LPMI's Dr Riddhi Shukla is a 'Co-sector Lead' for this years Leicester Business Festival
Improving diagnosis of the causes of heart failure
View photographs of the LPMI PhD Student Welcome Day 2018 event
New LPMI Funding Call Launched
The latest LPMI capacity building funding call is now open. We are interested in supporting projects (UoL applicants only) that develop novel methods for patient stratification, new diagnostics and/or therapeutic interventions that will improve the implementation of precision medicine. The current call particularly encourages applications encompassing Heath Data Research, personalised medicine approaches for multi-ethnic populations and projects using multi-omic methodologies.
Application deadline: 3 September 2018, 12:00pm
Latest funding opportunity from Office of Life Sciences and Innovate UK
The funding competition SME support to evaluate innovative medical technologies: round two opened for applications on 2 July 2018. SMEs can apply for a share of £1.5 million to support the evaluation, in a real world clinical setting, of innovative medical devices, diagnostics and regulated digital health products that address NHS priorities.
Key details to consider in potential partnering:
- For each grant award there can only be a single grant claimant and they must be an SME
- Any work carried out by universities or NHS is on a subcontracted basis (not as a collaborative partner)
- Eligible products must be CE marked before the application is made
- The product must be available for sale in the UK before the application is made
- The product cannot have been marketed in the UK for more than 5 years
Application deadline: 22 August 2018, 12:00pm
Professor Karen Brown talks about tamoxifen and breast cancer prevention on BBC radio 4 Inside Health
Listen to our Director Prof. Jacqui Shaw on the BBC World Service discussing the latest news on a blood test to detect 10 different cancers
Prof. Jacqui Shaw talks about the important role of liquid biopsies in cancer at the World Precision Medicine Congress
LPMI members attend IAX18
LPMI representation at the All-Party Parliamentary Group on Personalised Medicine
Prof Martin Tobin represented LPMI at a reception for the All Party Parliamentary Group on Personalised Medicine meeting on Wed 2nd May. The purpose of the group is to ensure that patients benefit from new and exciting medical innovations aimed at delivering personalised health care.
Key areas of interest to the party map well with areas of excellence in precision medicine in Leicester including the development and implementation of personalised medicine approaches in the treatment of lung cancer, cardiovascular disease and diabetes.
Great funding opportunity to help tackle a key global health challenge
Leicester tops the UK league for the increase in digital start up companies
£1M funding to support academics engaging with industry, increasing collaboration between the healthcare sector and academia to drive translational biomedical research.
Capacity-building Funding Call
This source provides flexible funding of up to £30,000 per project to drive precision medicine projects forward for up to six months. Come along to the funding call launch to find out more about LPMI and how to apply for funding on 29 November 2017 at 13.15-14.00 in the George Davies Centre, Lecture Theatre 2. Forms should be submitted before 12.00 (noon) Wed 3rd Jan 2018.
East Midlands life sciences researchers and GSK launch medicines discovery collaboration for lung disease
The Universities of Leicester and Nottingham have announced a new strategic research collaboration with GSK, using genetics to aid the development of new medicines for Chronic Obstructive Pulmonary Disease (COPD) and related airway disorders. The £1.24m investment over three years provides an East Midlands-focused boost to the Life Sciences Sector Deal of the UK Government’s Industrial Strategy.
Tumour analysis following surgery could provide breakthrough in predicting how well cancer patients respond to drug treatment
Life sciences: industrial strategy published 30 August 2017
Chief Medical Officer annual report 2016: Generation Genome published 4 July 2017
Professor Louise Wain has been awarded a personal Chair (Professorship) and a £400,000 grant to conduct ground-breaking research into two incurable lung conditions - chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF)
The prestigious award was jointly funded by the university, the British Lung Foundation, and GSK.